Cargando…
Correction: COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States
Autores principales: | Wang, Quan Qiu, Kaelber, David C., Xu, Rong, Volkow, Nora D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526074/ https://www.ncbi.nlm.nih.gov/pubmed/32999436 http://dx.doi.org/10.1038/s41380-020-00895-0 |
Ejemplares similares
-
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States
por: Wang, Quan Qiu, et al.
Publicado: (2020) -
Increased risk of COVID‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States
por: Wang, QuanQiu, et al.
Publicado: (2020) -
Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021
por: Wang, Lindsey, et al.
Publicado: (2021) -
Substance Use Disorders in Schizophrenia—Clinical Implications of Comorbidity
por: Volkow, Nora D.
Publicado: (2009) -
Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
por: Zeidan, Amer M., et al.
Publicado: (2023)